Taltz and Stable angina - a phase IV clinical study of FDA data

Summary:

Stable angina is reported as a side effect among people who take Taltz (ixekizumab), especially for people who are male, 50-59 old, also take Aspirin, and have Psoriasis.

The phase IV clinical study analyzes which people have Stable angina when taking Taltz. It is created by eHealthMe based on reports of 29,745 people who have side effects when taking Taltz from the FDA, and is updated regularly.

What is Taltz?

Taltz has active ingredients of ixekizumab. eHealthMe is studying from 29,778 Taltz users. Check the latest studies of Taltz.

What is Stable angina?

Stable angina (a constant chest pain) is found to be associated with 1,607 drugs and 2,103 conditions by eHealthMe. Check the latest studies of Stable angina.

On Aug, 07, 2026

29,745 people reported to have side effects when taking Taltz.
Among them, 11 people (0.04%) have Stable angina.

Among these 11 people:

What is the gender of people who have Stable angina when taking Taltz? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Stable angina when taking Taltz? *

What are other drugs people take besides Taltz? *

Aspirin: 5 people, 45.45%
Allopurinol: 4 people, 36.36%
Methylprednisolone: 4 people, 36.36%
Methotrexate: 3 people, 27.27%
Cosentyx: 2 people, 18.18%
Methotrexate Sodium: 2 people, 18.18%
Humira: 2 people, 18.18%
Naproxen: 1 person, 9.09%
Nortriptyline Hydrochloride: 1 person, 9.09%
Leflunomide: 1 person, 9.09%

What are other side effects people have besides Stable angina? *

Cardiac Failure: 4 people, 36.36%
Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 4 people, 36.36%
Muscle Aches (muscle pain): 3 people, 27.27%
Joint Pain: 3 people, 27.27%
Pain In Extremity: 2 people, 18.18%
Chest Pain: 2 people, 18.18%
Fatigue (feeling of tiredness): 2 people, 18.18%
Weakness: 2 people, 18.18%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 18.18%
Dizziness: 1 person, 9.09%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 7 people, 63.64%
Psoriasis (immune-mediated disease that affects the skin): 7 people, 63.64%
Stress And Anxiety: 1 person, 9.09%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 9.09%
Behcet's Syndrome (involves inflammation of the blood vessels): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Taltz and have Stable angina?

- Check whether Stable angina is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Taltz:

Taltz (29,778 reports)

Stable angina treatments and more:

Stable angina (63,199 reports)

Browse all side effects of Taltz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stable angina:

Stable angina (1,607 drugs)

Browse all the conditions that are associated with Stable angina:

Stable angina (2,103 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ixekizumab (the active ingredients of Taltz) and Taltz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.